StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
22
This year
2
Publishing Date
2024 - 02 - 20
1
2024 - 01 - 30
1
2023 - 12 - 21
1
2023 - 11 - 30
1
2023 - 09 - 06
1
2023 - 05 - 26
1
2023 - 05 - 09
1
2023 - 01 - 03
1
2022 - 12 - 30
1
2022 - 11 - 29
1
2022 - 10 - 07
1
2022 - 09 - 22
1
2022 - 07 - 22
1
2022 - 04 - 13
1
2022 - 01 - 31
1
2021 - 12 - 10
1
2021 - 12 - 06
1
2021 - 11 - 29
1
2021 - 10 - 22
1
2021 - 06 - 23
1
2021 - 03 - 04
1
2021 - 01 - 19
1
Sector
Communications
2
Health technology
22
N/a
1
Professional, scientific, and technical services
1
Retail trade
1
Tags
Acquisition
1
Agreement
1
Antibody
1
Antiviral
1
Approval
3
Asco
1
Bioforest
1
Biomidwest
1
Biotech-bay
2
Biotech-beach
2
Breast
1
Breast cancer
1
Cancer
4
Car-t
1
Cel
1
Change
1
China
1
Chmp
2
Clinical-trials-phase-iii
1
Collaboration
3
Commercialization
2
Covid
1
Covid-19
1
Deal
1
Disease
1
Drug
1
Fda
2
Funding
1
Genetown
1
Global
1
Komen
1
Leukemia
1
Liver
1
Lyn-005
1
Market
2
Million
1
Money
2
N/a
5
Negative
1
News
1
People
2
Pharmaceutical
1
Positive
1
Product-news
1
Regulatory
1
Report
1
Repurposed
1
Research
2
Schizophrenia
1
Series
2
Spac
1
Space
1
Study
1
Symposium
1
Syndros
1
T-cell
4
Therapeutics
5
Therapy
5
Trodelvy
2
Yescarta
2
Entities
3m company
73
Abb ltd
81
Abbott laboratories
101
Abbvie inc.
50
Air products and chemicals, inc.
34
Alphabet inc.
50
Apple inc.
49
Arcelormittal
34
Arrival
167
At&t inc.
36
Becton, dickinson and company
50
Bio-rad laboratories, inc.
33
Boston scientific corporation
41
Cisco systems, inc.
74
Concentrix corporation
32
Danaher corporation
45
Deere & company
31
Duke energy corporation
61
Eli lilly and company
84
Ericsson
97
Extreme networks, inc.
51
Fat projects acquisition corp
36
First bank
30
Ford motor company
37
Gartner, inc.
33
General electric company
61
Glaxosmithkline plc
40
Honeywell international inc.
92
Hubspot, inc.
30
Intel corporation
70
Johnson & johnson
305
Kering
42
Koninklijke philips n.v.
46
Lithium corp
50
Live nation entertainment, inc.
36
Lockheed martin corporation
44
Medtronic plc
82
Microsoft corporation
86
Morgan stanley
96
Morphosys ag
36
Nec corp
41
Nektar therapeutics
37
Nokia corp
32
Nokia corporation
33
Northrop grumman corporation
35
Novartis ag
55
Novo nordisk a/s
39
Oncocyte corporation
34
Oracle corporation
79
Orange
351
Panasonic corp
46
Pfizer, inc.
34
Sanofi
206
Sap se
67
Southern company (the)
38
Therapeuticsmd, inc.
33
Thermo fisher scientific inc
86
Vaxart, inc.
31
Verizon communications inc.
74
Wex inc.
32
Symbols
ABBV
1
ABT
2
ADXS
1
AMZN
1
AZN
1
AZNCF
1
BMY
2
CLVS
1
CLVSQ
1
DAWN
1
EXEL
1
FNCTF
2
GILD
22
GLAXF
1
GSK
1
IMGN
1
JNJ
2
LEGN
1
LLY
1
NRIX
1
NVS
2
NVSEF
2
OCUL
1
ONCY
1
PFE
1
SNY
3
SNYNF
3
Exchanges
Nasdaq
22
Nyse
4
Crawled Date
2024 - 02 - 20
1
2024 - 01 - 30
1
2023 - 12 - 21
1
2023 - 11 - 30
1
2023 - 09 - 06
1
2023 - 05 - 26
1
2023 - 05 - 09
1
2023 - 01 - 03
1
2022 - 12 - 30
1
2022 - 11 - 29
1
2022 - 10 - 07
1
2022 - 09 - 22
1
2022 - 07 - 22
1
2022 - 04 - 13
1
2022 - 01 - 31
1
2021 - 12 - 10
1
2021 - 12 - 06
1
2021 - 11 - 29
1
2021 - 10 - 22
1
2021 - 06 - 23
1
2021 - 03 - 04
1
2021 - 01 - 19
1
Crawled Time
00:00
19
00:20
2
01:00
17
02:00
2
03:00
3
04:00
3
04:20
1
06:00
5
07:00
7
08:00
6
09:00
7
09:52
1
10:00
7
10:51
1
11:00
33
11:33
3
12:00
41
12:03
1
12:06
1
12:15
12
12:20
6
12:30
1
12:34
1
13:00
44
13:01
1
13:07
1
13:15
5
13:17
1
13:20
19
13:27
1
13:30
3
13:52
1
14:00
39
14:01
1
14:03
2
14:15
3
14:20
6
14:30
10
15:00
22
15:15
2
15:17
1
15:20
3
15:30
4
15:49
1
15:56
1
15:59
1
16:00
14
16:20
2
17:00
17
17:43
1
18:00
12
18:11
1
18:32
1
19:00
11
19:47
1
20:00
24
21:00
17
21:03
1
22:00
27
23:00
19
Source
www.biospace.com
17
www.globenewswire.com
1
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Gilead sciences, inc.
crawled time :
15:00
save search
Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
Published:
2024-02-20
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-6.73%
|
O:
0.01%
H:
1.59%
C:
0.63%
antibody
collaboration
agreement
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
Published:
2024-01-30
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-15.57%
|
O:
-0.34%
H:
0.13%
C:
-0.23%
yescarta
fda
t-cell
change
approval
therapy
Lyndra Therapeutics Raises $101 Million in Series E Funding
Published:
2023-12-21
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-15.05%
|
O:
0.29%
H:
0.76%
C:
0.14%
million
series
therapeutics
funding
Gilead’s Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023
Published:
2023-11-30
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-11.26%
|
O:
0.2%
H:
1.8%
C:
1.62%
trodelvy
breast
symposium
cancer
Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million
Published:
2023-09-06
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-11.18%
|
O:
-0.05%
H:
0.03%
C:
-1.17%
series
total
deal
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting's Oral Presentations
Published:
2023-05-26
(Crawled : 15:00)
- prnewswire.com
DAWN
4
|
$14.98
-4.89%
-5.14%
1.4M
|
Professional, Scientific, and T...
|
24.05%
|
O:
0.33%
H:
4.21%
C:
3.06%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-49.07%
|
O:
-0.93%
H:
0.0%
C:
-18.22%
LEGN
|
$46.14
-2.08%
-2.12%
1.2M
|
Health Technology
|
-27.01%
|
O:
0.35%
H:
0.63%
C:
-0.58%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
126.05%
|
O:
0.07%
H:
2.53%
C:
1.23%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.02%
|
O:
0.45%
H:
0.79%
C:
-1.17%
asco
Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder
Published:
2023-05-09
(Crawled : 15:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-15.11%
|
O:
-0.66%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-15.05%
|
O:
-0.36%
H:
1.23%
C:
0.63%
lyn-005
schizophrenia
trial
therapeutics
study
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
Published:
2023-01-03
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-22.24%
|
O:
-0.9%
H:
1.25%
C:
0.36%
collaboration
therapeutics
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.69%
|
O:
0.77%
H:
0.0%
C:
-0.74%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.81%
|
O:
1.08%
H:
0.0%
C:
-0.25%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-49.35%
|
O:
-0.08%
H:
0.21%
C:
-0.1%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
3.01%
|
O:
-0.01%
H:
0.08%
C:
-0.95%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.7%
|
O:
-0.04%
H:
0.16%
C:
-0.47%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-32.14%
|
O:
0.04%
H:
0.21%
C:
-0.25%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.63%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-21.7%
|
O:
0.08%
H:
0.66%
C:
0.61%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
43.81%
|
O:
-0.32%
H:
2.91%
C:
2.75%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.66%
|
O:
-0.46%
H:
0.38%
C:
0.01%
global
disease
report
therapeutics
cancer
market
Thryv Therapeutics Inc. announces the appointment of Pharmaceutical Commercialization Expert Melissa Koomey, M.B.A., to its Board of Directors
Published:
2022-11-29
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-21.65%
|
O:
0.34%
H:
0.43%
C:
0.3%
commercialization
therapeutics
Movers & Shakers: New C-Suites for Assembly Biosciences, Urica Therapeutics, BlueSphere Bio and More
Published:
2022-10-07
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
11.7%
|
O:
-4.81%
H:
0.0%
C:
-2.52%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
4.71%
|
O:
0.05%
H:
2.53%
C:
-0.69%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
18.73%
|
O:
0.46%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
2.79%
|
O:
-0.48%
H:
0.7%
C:
-0.54%
ADXS
|
$0.57
12.48%
9.5K
|
Health Technology
|
-71.64%
|
O:
-0.5%
H:
5.0%
C:
2.0%
Susan G. Komen® MORE THAN PINK Walk Raises Money To Improve Outcomes For Breast Cancer Patients
Published:
2022-09-22
(Crawled : 15:00)
- prnewswire.com
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
5.13%
|
O:
-0.24%
H:
1.52%
C:
0.66%
komen
cancer
Kite’s CAR T-cell Therapy Tecartus® Receives Positive CHMP Opinion in Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL)
Published:
2022-07-22
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
9.42%
|
O:
0.43%
H:
0.86%
C:
-0.77%
tecartus
chmp
t-cell
leukemia
positive
therapy
Antiviral Drugs Market Size To Reach USD 50.02 BN In 2030 Due to Development Of New, Improved, And More Advanced Formulations, Such As Repurposed Drugs And Drug Combination Therapies, Says Reports and Data
Published:
2022-04-13
(Crawled : 15:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-28.97%
|
O:
1.76%
H:
0.35%
C:
0.35%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.54%
|
O:
0.45%
H:
0.0%
C:
-0.83%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.82%
|
O:
0.12%
H:
0.44%
C:
0.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-17.63%
|
O:
0.08%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-15.03%
|
O:
-0.24%
H:
0.45%
C:
0.39%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-36.08%
|
O:
0.24%
H:
0.53%
C:
0.18%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-0.54%
|
O:
-1.38%
H:
0.0%
C:
-3.67%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
8.32%
|
O:
-0.02%
H:
0.8%
C:
0.71%
drug
antiviral
repurposed
market
U.S. FDA Approves New Label Update for CAR T-Cell Therapy Yescarta® Showing Prophylactic Steriod Use Improves Management of Cytokine Release Syndrome
Published:
2022-01-31
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-3.05%
|
O:
-0.32%
H:
0.31%
C:
0.06%
yescarta
fda
cel
therapy
t-cell
syndros
Trodelvy® Demonstrates Clinical Benefit for Black Patients Consistent with Full Metastatic Triple-Negative Breast Cancer Population in ASCENT Study
Published:
2021-12-10
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-5.04%
|
O:
-0.17%
H:
0.0%
C:
0.0%
trodelvy
cancer
negative
breast cancer
CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19
Published:
2021-12-06
(Crawled : 15:00)
- globenewswire.com
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-4.03%
|
O:
-0.07%
H:
0.0%
C:
0.0%
approval
covid
chmp
covid-19
Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients
Published:
2021-11-29
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-4.64%
|
O:
0.74%
H:
0.0%
C:
0.0%
AMZN
|
$174.63
-2.56%
-2.63%
54M
|
Retail Trade
|
-95.02%
|
O:
1.2%
H:
0.0%
C:
0.0%
liver
collaboration
BioSpace Movers & Shakers, Oct. 22
Published:
2021-10-22
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-6.36%
|
O:
-1.1%
H:
0.0%
C:
-0.41%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
201.16%
|
O:
-0.09%
H:
1.28%
C:
1.16%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-14.21%
|
O:
0.37%
H:
1.06%
C:
0.96%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.91%
|
O:
0.41%
H:
0.0%
C:
0.0%
OCUL
|
$5.22
-10.92%
-12.26%
9.1M
|
Health Technology
|
-51.8%
|
O:
-27.15%
H:
0.89%
C:
-12.42%
NRIX
3 d
|
$13.6
-5.82%
-6.18%
1M
|
Health Technology
|
-51.74%
|
O:
0.43%
H:
0.11%
C:
-0.81%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-0.34%
|
O:
0.24%
H:
0.0%
C:
0.0%
space
spac
China Approves Its First Commercial CAR T-Cell Therapy
Published:
2021-06-23
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-0.43%
|
O:
0.24%
H:
0.06%
C:
-0.83%
china
therapy
t-cell
approval
car-t
commercialization
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.